Related Experiment Videos
Protein kinases in normal and transformed melanocytes
R Y Quong1, S T Bickford, Y L Ing
1Department of Medicine, University of Toronto, Ontario, Canada.
Melanoma Research
|October 1, 1994
Summary
Aberrant protein kinase function is key in melanoma. Researchers identified specific protein kinases, including UFO/AXL and KDR, with altered expression in melanoma cells compared to normal melanocytes, offering potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Aberrant protein kinase function is a known factor in melanoma development.
- Understanding molecular events in melanoma initiation and progression is crucial.
Purpose of the Study:
- To identify protein kinases involved in melanoma using molecular techniques.
- To analyze the expression patterns of identified protein kinases in normal and cancerous melanocytes.
Main Methods:
- Reverse Transcription Polymerase Chain Reaction (RT-PCR) was employed to detect protein kinases.
- Northern blot analysis was used to examine mRNA expression levels.
Main Results:
- Seven known protein kinases (JAK-1, TYK02, AXL/UFO, IGF1-R, KDR, FER) and MLK-3/PTK1 were identified.
- UFO/AXL and KDR messenger RNAs (mRNAs) showed higher expression in some melanoma cell lines.
- Other identified protein kinases exhibited similar expression levels in both normal and transformed melanocytes.
Conclusions:
- Specific protein kinases, notably UFO/AXL and KDR, display altered expression in melanoma.
- These findings contribute to understanding the molecular basis of melanoma.
- Identified kinases may represent potential targets for melanoma therapy.